History

JGL is a flexible, medium-sized pharmaceutical company, producing primarily generics, developed from a central laboratory for manufacturing and controlling magistral and galenic preparations for the "JADRAN" Rijeka pharmacy. It was founded in 1991 as the first entirely private pharmaceutical joint stock company in Croatia. The company headquarters is in Rijeka.

The transformation from a local laboratory into a powerful and fast-growing pharmaceutical company occurred exclusively through organic growth - development of new products and conquering new markets.

To stimulate the achiever attitude, our internal conversations always go back to the company beginnings and the story of a pastry mixer, which started the existing production plant, fully compliant with international standards of good manufacturing and laboratory practice in drug production and control (GMP/GLP - Good Manufacture Practice/Good Laboratory Practice).

The beginning of JGL market operation was characterized by an entrepreneurial spirit of its founders, who used the niche strategy with several pharmacologically essential drugs, produced on a small scale (potassium chloride tablets, Timalen eye drops, Hepan and Fluacet gels, Atyrazol tablets), recognising the market potential for these products. Their quick and flexible entry into the market resulted in a fast company growth.

Year 1991 marked the first registered drug, Carbo Medicinalis (activated medicinal charcoal) which, being a classical adsorbent and an antidote is still an obligatory product in the treatment of poisoning and diarrhoea.

Systematic investments into employee knowledge and new product development, in addition to a close relationship with our customers and investments into modern technology for manufacturing and controlling drugs have resulted in JGL becoming the third pharmaceutical company in Croatia, developed from the initial small enterprise over a relatively short period of time.

Timeline